本頁面由Tiger Trade Technology Pte. Ltd.提供服務

TALKMED集團

0.455
0.000
成交量:- -
成交額:- -
市值:6.05億
市盈率:13.91
高:0.455
開:0.455
低:0.455
收:0.455
52周最高:0.500
52周最低:0.430
股本:13.30億
流通股本:1.93億
量比:- -
換手率:- -
股息:0.01
股息率:1.98%
每股收益(TTM):0.033
每股收益(LYR):0.033
淨資產收益率:52.83%
總資產收益率:18.02%
市淨率:7.21
市盈率(LYR):13.78

資料載入中...

公司資料

公司名字:
TALKMED集團
交易所:
SGX
成立時間:
- -
員工人數:
- -
公司地址:
- -
郵編:
- -
電話:
- -
傳真:
- -
簡介:
TalkMed Group Limited is a Singapore-based investment holding company. The Company provides medical oncology and palliative care healthcare services in Singapore. Its oncology specialist specializes in providing medical oncology services targeting various cancers, such as breast cancer, colon cancer, lung cancer, liver, biliary and pancreatic cancers, gastro-intestinal cancers, head and neck cancers, leukemia, hematology malignancies and brain cancer. The Company, through the Parkway Cancer Centre (PCC)-vehicle, offers a support system to cater to the psychosocial needs of its patients and their families. The Company, through Singapore Cancer Centre (SCC) and the Parkway Cancer Centre (PCC) vehicle, provides CANSCREEN, a screening program that provides screening for individuals at a higher risk of getting cancer. The Company offers cellular and gene therapy related products and services. It also operates in Vietnam, Hong Kong and the People's Republic of China.